Tatva Chintan Pharma Chem Ltd
NSE :TATVA BSE :543321 Sector : ChemicalsBuy, Sell or Hold TATVA? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
02 May 1228.15 (0.00%) | 30 Apr 1228.10 (-0.10%) | 29 Apr 1229.30 (-0.85%) | 26 Apr 1239.90 (-0.39%) | 25 Apr 1244.70 (-0.65%) | 24 Apr 1252.85 (1.16%) | 23 Apr 1238.45 (0.39%) | 22 Apr 1233.60 (1.52%) | 19 Apr 1215.10 (-0.88%) | 18 Apr 1225.85 (-0.76%) | 16 Apr 1235.30 (0.25%) | 15 Apr 1232.25 (-2.72%) | 12 Apr 1266.65 (-1.65%) | 10 Apr 1287.90 (2.05%) | 09 Apr 1262.05 (-0.91%) | 08 Apr 1273.70 (-1.12%) | 05 Apr 1288.15 (3.45%) | 04 Apr 1245.20 (2.15%) | 03 Apr 1219.05 (5.95%) | 02 Apr 1150.55 (2.77%) | 01 Apr 1119.50 (3.79%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Bullish
Long Term Investors
Bearish
Moving Averages
5 DMA
Bearish
1233.86
10 DMA
Bearish
1233.51
20 DMA
Bearish
1240.01
50 DMA
Bullish
1216.62
100 DMA
Bearish
1344.2
200 DMA
Bearish
1473.2
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On May 02, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1251.8 | 1243.65 | 1232.52 | - | - |
R2 | 1243.65 | 1237.58 | 1231.07 | 1243.75 | - |
R1 | 1235.9 | 1233.82 | 1229.61 | 1236.1 | 1239.78 |
P | 1227.75 | 1227.75 | 1227.75 | 1227.85 | 1229.69 |
S1 | 1220 | 1221.68 | 1226.69 | 1220.2 | 1223.88 |
S2 | 1211.85 | 1217.92 | 1225.24 | 1211.95 | - |
S3 | 1204.1 | 1211.85 | 1223.78 | - | - |
Key Metrics
EPS
17.46
P/E
70.27
P/B
4.01
Dividend Yield
0.15%
Market Cap
2,873 Cr.
Face Value
10
Book Value
306.3
ROE
9.21%
EBITDA Growth
11.2 Cr.
Debt/Equity
0.29
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Tatva Chintan Pharma Chem Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 121.68 | 125.36 | 115.38 | 97.43 | 85.42 |
PROFIT | 11.62 | 20.54 | 9.5 | 7.78 | 3.46 |
EPS | 5.24 | 7.65 | 4.29 | 3.43 | 1.48 |
Tatva Chintan Pharma Chem Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 114.61 | 120.19 | 107.12 | 93.33 | 87.28 |
PROFIT | 10.56 | 19.74 | 8.25 | 8.2 | 4.65 |
EPS | 4.76 | 7.29 | 3.72 | 3.63 | 1.99 |
Profit & Loss (Figures in Rs. Crores)
Tatva Chintan Pharma Chem Ltd Profit & Loss
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 140.37 | 211.88 | 280.46 | 309.62 | 506.2 | 423.64 | |
PROFIT | 12.28 | 19.98 | 37.82 | 52.29 | 95.91 | 48.85 | |
EPS | 0 | 0 | 0 | 0 | 43.25 | 20.52 |
Tatva Chintan Pharma Chem Ltd Profit & Loss
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 136.92 | 207.2 | 270.43 | 301.49 | 496.48 | 402.21 | |
PROFIT | 11.05 | 19.62 | 34.98 | 51.39 | 96.03 | 43.88 | |
EPS | 13.74 | 25.12 | 43.51 | 25.57 | 43.31 | 18.26 |
Balance Sheet (Figures in Rs. Crores)
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
SOURCES OF FUNDS : | ||||||
Share Capital | 22.17 | 22.17 | 20.09 | 8.04 | 8.04 | 8.04 |
Reserves Total | 492.63 | 450.92 | 145.88 | 109.66 | 71.67 | 51.08 |
Total Shareholders Funds | 514.8 | 473.09 | 165.97 | 117.7 | 79.71 | 59.12 |
Secured Loans | 170.26 | 119.94 | 90.25 | 90.69 | 77.15 | 56.15 |
Total Debt | 170.26 | 119.94 | 90.25 | 90.69 | 77.15 | 56.15 |
Other Liabilities | 1.15 | 0.66 | 1.98 | 0.43 | 0.33 | 0.16 |
Total Liabilities | 686.21 | 593.69 | 258.2 | 208.82 | 157.19 | 115.43 |
APPLICATION OF FUNDS : | ||||||
Gross Block | 231.78 | 186.14 | 138.88 | 122.48 | 73.46 | 59.99 |
Less: Accumulated Depreciation | 35.53 | 26.53 | 18.44 | 11.3 | 6.74 | 2.95 |
Net Block | 196.25 | 159.61 | 120.44 | 111.18 | 66.72 | 57.04 |
Capital Work in Progress | 230.74 | 51.49 | 9.81 | 4.89 | 6.04 | 9.94 |
Investments | 0 | 0 | 0 | 0 | 0 | 0.53 |
Inventories | 162.5 | 169.96 | 72.02 | 63.56 | 35.59 | 28.82 |
Sundry Debtors | 84.4 | 56.6 | 90.74 | 49.57 | 41.26 | 28.81 |
Cash and Bank Balance | 44.76 | 176.99 | 5.34 | 10.83 | 15.75 | 7.76 |
Loans and Advances | 21.89 | 32.1 | 16.15 | 8.74 | 21.79 | 10.59 |
Total Current Assets | 313.55 | 435.64 | 184.25 | 132.7 | 114.38 | 75.97 |
Current Liabilities | 69.56 | 63.17 | 54.03 | 35.61 | 26.99 | 26.65 |
Provisions | 0.55 | 1.2 | 0.5 | 0.06 | 0.04 | 0.03 |
Total Current Liabilities & Provisions | 70.11 | 64.37 | 54.53 | 35.67 | 27.03 | 26.68 |
Net Current Assets | 243.44 | 371.27 | 129.72 | 97.02 | 87.35 | 49.29 |
Deferred Tax Assets | 25.02 | 19.65 | 7.22 | 1.35 | 0.15 | 0.69 |
Deferred Tax Liability | 12.66 | 10.94 | 9.3 | 5.8 | 3.45 | 2.3 |
Net Deferred Tax | 12.36 | 8.71 | -2.08 | -4.45 | -3.3 | -1.61 |
Other Assets | 3.4 | 2.6 | 0.3 | 0.17 | 0.38 | 0.23 |
Total Assets | 686.19 | 593.68 | 258.2 | 208.81 | 157.18 | 115.42 |
Contingent Liabilities | 1.46 | 3.34 | 0.51 | 0.7 | 0 | 0.41 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
SOURCES OF FUNDS : | ||||||
Share Capital | 22.17 | 22.17 | 20.09 | 8.04 | 8.04 | 8.04 |
Reserves Total | 482.62 | 446.71 | 141.85 | 106.41 | 71.6 | 51.45 |
Total Shareholders Funds | 504.79 | 468.88 | 161.94 | 114.45 | 79.64 | 59.49 |
Secured Loans | 170.26 | 119.94 | 90.25 | 90.69 | 77.15 | 56.15 |
Total Debt | 170.26 | 119.94 | 90.25 | 90.69 | 77.15 | 56.15 |
Other Liabilities | 1.15 | 0.66 | 1.98 | 0.43 | 0.33 | 0.16 |
Total Liabilities | 676.2 | 589.48 | 254.17 | 205.57 | 157.12 | 115.8 |
APPLICATION OF FUNDS : | ||||||
Gross Block | 231.75 | 186.14 | 138.88 | 122.48 | 73.45 | 59.98 |
Less : Accumulated Depreciation | 35.53 | 26.53 | 18.43 | 11.3 | 6.74 | 2.95 |
Net Block | 196.22 | 159.61 | 120.45 | 111.18 | 66.71 | 57.03 |
Capital Work in Progress | 230.74 | 51.49 | 9.81 | 4.89 | 6.04 | 9.94 |
Investments | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 1.2 |
Inventories | 151.45 | 160.69 | 68.36 | 58.72 | 31.06 | 25.75 |
Sundry Debtors | 90.04 | 61.6 | 90.34 | 50.97 | 44.65 | 32.88 |
Cash and Bank Balance | 38.58 | 174.74 | 3.59 | 9.82 | 15.67 | 7.17 |
Loans and Advances | 31.39 | 56.09 | 16.18 | 8.89 | 22.2 | 10.46 |
Total Current Assets | 311.46 | 453.12 | 178.47 | 128.4 | 113.57 | 76.25 |
Current Liabilities | 78.34 | 86.36 | 53.24 | 35.22 | 26.91 | 27.23 |
Provisions | 0.33 | 0.37 | 0.2 | 0.06 | 0.04 | 0.03 |
Total Current Liabilities & Provisions | 78.67 | 86.73 | 53.44 | 35.29 | 26.94 | 27.25 |
Net Current Assets | 232.79 | 366.39 | 125.03 | 93.11 | 86.63 | 49 |
Deferred Tax Assets | 25.02 | 19.65 | 7.22 | 1.35 | 0.15 | 0.69 |
Deferred Tax Liability | 12.66 | 10.94 | 9.3 | 5.8 | 3.45 | 2.3 |
Net Deferred Tax | 12.36 | 8.71 | -2.08 | -4.45 | -3.3 | -1.61 |
Other Assets | 3.4 | 2.6 | 0.3 | 0.17 | 0.38 | 0.23 |
Total Assets | 676.19 | 589.47 | 254.18 | 205.57 | 157.12 | 115.8 |
Contingent Liabilities | 1.46 | 3.34 | 0.51 | 0.68 | 0.43 | 0 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 44.78 |
Depreciation | 9.56 |
Interest (Net) | 3.08 |
P/L in Forex | 3.6 |
Total Adjustments (PBT and Ext... | 20.71 |
Operating Profit before Workin... | 65.49 |
Trade and 0ther Receivables | -31.44 |
Inventories | 7.46 |
Trade Payables | -12.66 |
Total Adjustments (OP before W... | -28.42 |
Cash Generated from/(used in) ... | 37.07 |
Direct Taxes Paid | -9.29 |
Total Adjustments(Cash Generat... | -9.29 |
Cash Flow before Extraordinary... | 27.78 |
Net Cash from Operating Activi... | 27.78 |
Purchased of Fixed Assets | -203.11 |
Sale of Fixed Assets | 0.07 |
Interest Received | 5.33 |
Net Cash used in Investing Act... | -101.23 |
Proceed from 0ther Long Term B... | 0.83 |
Proceed from Short Tem Borrowi... | 63.74 |
Of the Long Tem Borrowings | -13.94 |
Dividend Paid | -4.43 |
Interest Paid | -8.4 |
Net Cash used in Financing Act... | 37.8 |
Net Profit before Tax and Extr... | 38.83 |
Depreciation | 9.55 |
Interest (Net) | 3.06 |
P/L in Forex | -0.49 |
Total Adjustments (PBT and Ext... | 15.82 |
Operating Profit before Workin... | 54.65 |
Trade and 0ther Receivables | -27.88 |
Inventories | 9.24 |
Trade Payables | -12.64 |
Total Adjustments (OP before W... | -23.18 |
Cash Generated from/(used in) ... | 31.47 |
Direct Taxes Paid | -7.74 |
Total Adjustments(Cash Generat... | -7.74 |
Cash Flow before Extraordinary... | 23.73 |
Net Cash from Operating Activi... | 23.73 |
Purchased of Fixed Assets | -203.09 |
Sale of Fixed Assets | 0.07 |
Interest Received | 5.33 |
Net Cash used in Investing Act... | -101.13 |
Proceed from 0ther Long Term B... | 0.83 |
Proceed from Short Tem Borrowi... | 63.74 |
Of the Long Tem Borrowings | -13.94 |
Dividend Paid | -4.43 |
Interest Paid | -8.38 |
Net Cash used in Financing Act... | 37.81 |
Company Details
Registered Office |
|
Address | No 502/17 GIDC Estate, Ankleshwar |
City | Bharuch |
State | Gujarat |
Pin Code | 393002 |
Tel. No. | +91-75730-46951/46952 |
Fax. No. | |
cs@tatvachintan.com | |
Internet | http://www.tatvachintan.com |
Registrars |
|
Address | No 502/17 GIDC Estate |
City | Bharuch |
State | Gujarat |
Pin Code | 393002 |
Tel. No. | +91-75730-46951/46952 |
Fax. No. | |
cs@tatvachintan.com | |
Internet | http://www.tatvachintan.com |
Management |
|
Name | Designation |
Chintan Nitinkumar Shah | Chairman / Executive Director |
Ajaykumar Mansukhlal Patel | WTD & Executive Director |
Shekhar Rasiklal Somani | WTD & Executive Director |
Subhash Patel | Independent Non Exe. Director |
Avani Rajesh Umatt | Independent Non Exe. Director |
Manher Chinmanlal Desai | Independent Non Exe. Director |